End Stage Renal Disease Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 102 pages | ID: EDE1DA9E62ACEN
Market Monitor Global

Abstracts

End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.

This report contains market size and forecasts of End Stage Renal Disease Treatment in Global, including the following market information:

Global End Stage Renal Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global End Stage Renal Disease Treatment market was valued at 56940 million in 2021 and is projected to reach US$ 81330 million by 2028, at a CAGR of 5.2% during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hemodialysis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of End Stage Renal Disease Treatment include Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO and Newsol, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the End Stage Renal Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global End Stage Renal Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global End Stage Renal Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Hemodialysis
• Peritoneal Dialysis
• Kidney Transplantation

Global End Stage Renal Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global End Stage Renal Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Kidney Dialysis Centers
• At Homes
• Others

Global End Stage Renal Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global End Stage Renal Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies End Stage Renal Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies End Stage Renal Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Fresenius
• DaVita
• Baxter
• Nipro
• B. Braun
• Asahi Kasei
• Nikkiso
• WEGO
• Newsol
• Mayo Clinic
• Guangdong Biolight
• Medtronic
• Sanxin Medtec
• Jafron Biomedical
• SWS Hemodialysis Care
• Tianyi Medical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 End Stage Renal Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global End Stage Renal Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL END STAGE RENAL DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global End Stage Renal Disease Treatment Market Size: 2021 VS 2028
2.2 Global End Stage Renal Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top End Stage Renal Disease Treatment Players in Global Market
3.2 Top Global End Stage Renal Disease Treatment Companies Ranked by Revenue
3.3 Global End Stage Renal Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 End Stage Renal Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies End Stage Renal Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 End Stage Renal Disease Treatment Players in Global Market
  3.6.1 List of Global Tier 1 End Stage Renal Disease Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 End Stage Renal Disease Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global End Stage Renal Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Hemodialysis
  4.1.3 Peritoneal Dialysis
  4.1.4 Kidney Transplantation
4.2 By Type - Global End Stage Renal Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global End Stage Renal Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global End Stage Renal Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global End Stage Renal Disease Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global End Stage Renal Disease Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Kidney Dialysis Centers
  5.1.4 At Homes
  5.1.5 Others
5.2 By Application - Global End Stage Renal Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global End Stage Renal Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global End Stage Renal Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global End Stage Renal Disease Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global End Stage Renal Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global End Stage Renal Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global End Stage Renal Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global End Stage Renal Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global End Stage Renal Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America End Stage Renal Disease Treatment Revenue, 2017-2028
  6.3.2 US End Stage Renal Disease Treatment Market Size, 2017-2028
  6.3.3 Canada End Stage Renal Disease Treatment Market Size, 2017-2028
  6.3.4 Mexico End Stage Renal Disease Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe End Stage Renal Disease Treatment Revenue, 2017-2028
  6.4.2 Germany End Stage Renal Disease Treatment Market Size, 2017-2028
  6.4.3 France End Stage Renal Disease Treatment Market Size, 2017-2028
  6.4.4 U.K. End Stage Renal Disease Treatment Market Size, 2017-2028
  6.4.5 Italy End Stage Renal Disease Treatment Market Size, 2017-2028
  6.4.6 Russia End Stage Renal Disease Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries End Stage Renal Disease Treatment Market Size, 2017-2028
  6.4.8 Benelux End Stage Renal Disease Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia End Stage Renal Disease Treatment Revenue, 2017-2028
  6.5.2 China End Stage Renal Disease Treatment Market Size, 2017-2028
  6.5.3 Japan End Stage Renal Disease Treatment Market Size, 2017-2028
  6.5.4 South Korea End Stage Renal Disease Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia End Stage Renal Disease Treatment Market Size, 2017-2028
  6.5.6 India End Stage Renal Disease Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America End Stage Renal Disease Treatment Revenue, 2017-2028
  6.6.2 Brazil End Stage Renal Disease Treatment Market Size, 2017-2028
  6.6.3 Argentina End Stage Renal Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa End Stage Renal Disease Treatment Revenue, 2017-2028
  6.7.2 Turkey End Stage Renal Disease Treatment Market Size, 2017-2028
  6.7.3 Israel End Stage Renal Disease Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia End Stage Renal Disease Treatment Market Size, 2017-2028
  6.7.5 UAE End Stage Renal Disease Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Fresenius
  7.1.1 Fresenius Corporate Summary
  7.1.2 Fresenius Business Overview
  7.1.3 Fresenius End Stage Renal Disease Treatment Major Product Offerings
  7.1.4 Fresenius End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.1.5 Fresenius Key News
7.2 DaVita
  7.2.1 DaVita Corporate Summary
  7.2.2 DaVita Business Overview
  7.2.3 DaVita End Stage Renal Disease Treatment Major Product Offerings
  7.2.4 DaVita End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.2.5 DaVita Key News
7.3 Baxter
  7.3.1 Baxter Corporate Summary
  7.3.2 Baxter Business Overview
  7.3.3 Baxter End Stage Renal Disease Treatment Major Product Offerings
  7.3.4 Baxter End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.3.5 Baxter Key News
7.4 Nipro
  7.4.1 Nipro Corporate Summary
  7.4.2 Nipro Business Overview
  7.4.3 Nipro End Stage Renal Disease Treatment Major Product Offerings
  7.4.4 Nipro End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.4.5 Nipro Key News
7.5 B. Braun
  7.5.1 B. Braun Corporate Summary
  7.5.2 B. Braun Business Overview
  7.5.3 B. Braun End Stage Renal Disease Treatment Major Product Offerings
  7.5.4 B. Braun End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.5.5 B. Braun Key News
7.6 Asahi Kasei
  7.6.1 Asahi Kasei Corporate Summary
  7.6.2 Asahi Kasei Business Overview
  7.6.3 Asahi Kasei End Stage Renal Disease Treatment Major Product Offerings
  7.6.4 Asahi Kasei End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.6.5 Asahi Kasei Key News
7.7 Nikkiso
  7.7.1 Nikkiso Corporate Summary
  7.7.2 Nikkiso Business Overview
  7.7.3 Nikkiso End Stage Renal Disease Treatment Major Product Offerings
  7.7.4 Nikkiso End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.7.5 Nikkiso Key News
7.8 WEGO
  7.8.1 WEGO Corporate Summary
  7.8.2 WEGO Business Overview
  7.8.3 WEGO End Stage Renal Disease Treatment Major Product Offerings
  7.8.4 WEGO End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.8.5 WEGO Key News
7.9 Newsol
  7.9.1 Newsol Corporate Summary
  7.9.2 Newsol Business Overview
  7.9.3 Newsol End Stage Renal Disease Treatment Major Product Offerings
  7.9.4 Newsol End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.9.5 Newsol Key News
7.10 Mayo Clinic
  7.10.1 Mayo Clinic Corporate Summary
  7.10.2 Mayo Clinic Business Overview
  7.10.3 Mayo Clinic End Stage Renal Disease Treatment Major Product Offerings
  7.10.4 Mayo Clinic End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.10.5 Mayo Clinic Key News
7.11 Guangdong Biolight
  7.11.1 Guangdong Biolight Corporate Summary
  7.11.2 Guangdong Biolight Business Overview
  7.11.3 Guangdong Biolight End Stage Renal Disease Treatment Major Product Offerings
  7.11.4 Guangdong Biolight End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.11.5 Guangdong Biolight Key News
7.12 Medtronic
  7.12.1 Medtronic Corporate Summary
  7.12.2 Medtronic Business Overview
  7.12.3 Medtronic End Stage Renal Disease Treatment Major Product Offerings
  7.12.4 Medtronic End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.12.5 Medtronic Key News
7.13 Sanxin Medtec
  7.13.1 Sanxin Medtec Corporate Summary
  7.13.2 Sanxin Medtec Business Overview
  7.13.3 Sanxin Medtec End Stage Renal Disease Treatment Major Product Offerings
  7.13.4 Sanxin Medtec End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.13.5 Sanxin Medtec Key News
7.14 Jafron Biomedical
  7.14.1 Jafron Biomedical Corporate Summary
  7.14.2 Jafron Biomedical Business Overview
  7.14.3 Jafron Biomedical End Stage Renal Disease Treatment Major Product Offerings
  7.14.4 Jafron Biomedical End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.14.5 Jafron Biomedical Key News
7.15 SWS Hemodialysis Care
  7.15.1 SWS Hemodialysis Care Corporate Summary
  7.15.2 SWS Hemodialysis Care Business Overview
  7.15.3 SWS Hemodialysis Care End Stage Renal Disease Treatment Major Product Offerings
  7.15.4 SWS Hemodialysis Care End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.15.5 SWS Hemodialysis Care Key News
7.16 Tianyi Medical
  7.16.1 Tianyi Medical Corporate Summary
  7.16.2 Tianyi Medical Business Overview
  7.16.3 Tianyi Medical End Stage Renal Disease Treatment Major Product Offerings
  7.16.4 Tianyi Medical End Stage Renal Disease Treatment Revenue in Global Market (2017-2022)
  7.16.5 Tianyi Medical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. End Stage Renal Disease Treatment Market Opportunities & Trends in Global Market
Table 2. End Stage Renal Disease Treatment Market Drivers in Global Market
Table 3. End Stage Renal Disease Treatment Market Restraints in Global Market
Table 4. Key Players of End Stage Renal Disease Treatment in Global Market
Table 5. Top End Stage Renal Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global End Stage Renal Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global End Stage Renal Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies End Stage Renal Disease Treatment Product Type
Table 9. List of Global Tier 1 End Stage Renal Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 End Stage Renal Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global End Stage Renal Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - End Stage Renal Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - End Stage Renal Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global End Stage Renal Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - End Stage Renal Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - End Stage Renal Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global End Stage Renal Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global End Stage Renal Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global End Stage Renal Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America End Stage Renal Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe End Stage Renal Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia End Stage Renal Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America End Stage Renal Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa End Stage Renal Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Fresenius Corporate Summary
Table 31. Fresenius End Stage Renal Disease Treatment Product Offerings
Table 32. Fresenius End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. DaVita Corporate Summary
Table 34. DaVita End Stage Renal Disease Treatment Product Offerings
Table 35. DaVita End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Baxter Corporate Summary
Table 37. Baxter End Stage Renal Disease Treatment Product Offerings
Table 38. Baxter End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Nipro Corporate Summary
Table 40. Nipro End Stage Renal Disease Treatment Product Offerings
Table 41. Nipro End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. B. Braun Corporate Summary
Table 43. B. Braun End Stage Renal Disease Treatment Product Offerings
Table 44. B. Braun End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Asahi Kasei Corporate Summary
Table 46. Asahi Kasei End Stage Renal Disease Treatment Product Offerings
Table 47. Asahi Kasei End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Nikkiso Corporate Summary
Table 49. Nikkiso End Stage Renal Disease Treatment Product Offerings
Table 50. Nikkiso End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. WEGO Corporate Summary
Table 52. WEGO End Stage Renal Disease Treatment Product Offerings
Table 53. WEGO End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Newsol Corporate Summary
Table 55. Newsol End Stage Renal Disease Treatment Product Offerings
Table 56. Newsol End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Mayo Clinic Corporate Summary
Table 58. Mayo Clinic End Stage Renal Disease Treatment Product Offerings
Table 59. Mayo Clinic End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Guangdong Biolight Corporate Summary
Table 61. Guangdong Biolight End Stage Renal Disease Treatment Product Offerings
Table 62. Guangdong Biolight End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Medtronic Corporate Summary
Table 64. Medtronic End Stage Renal Disease Treatment Product Offerings
Table 65. Medtronic End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Sanxin Medtec Corporate Summary
Table 67. Sanxin Medtec End Stage Renal Disease Treatment Product Offerings
Table 68. Sanxin Medtec End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Jafron Biomedical Corporate Summary
Table 70. Jafron Biomedical End Stage Renal Disease Treatment Product Offerings
Table 71. Jafron Biomedical End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 72. SWS Hemodialysis Care Corporate Summary
Table 73. SWS Hemodialysis Care End Stage Renal Disease Treatment Product Offerings
Table 74. SWS Hemodialysis Care End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Tianyi Medical Corporate Summary
Table 76. Tianyi Medical End Stage Renal Disease Treatment Product Offerings
Table 77. Tianyi Medical End Stage Renal Disease Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. End Stage Renal Disease Treatment Segment by Type in 2021
Figure 2. End Stage Renal Disease Treatment Segment by Application in 2021
Figure 3. Global End Stage Renal Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global End Stage Renal Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global End Stage Renal Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by End Stage Renal Disease Treatment Revenue in 2021
Figure 8. By Type - Global End Stage Renal Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global End Stage Renal Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global End Stage Renal Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America End Stage Renal Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe End Stage Renal Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia End Stage Renal Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America End Stage Renal Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa End Stage Renal Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE End Stage Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Fresenius End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. DaVita End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Baxter End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Nipro End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. B. Braun End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Asahi Kasei End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Nikkiso End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. WEGO End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Newsol End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Mayo Clinic End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Guangdong Biolight End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Medtronic End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Sanxin Medtec End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Jafron Biomedical End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. SWS Hemodialysis Care End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Tianyi Medical End Stage Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)